Market Overview

Oppenheimer Reiterates Outperform on Alimera Sciences, Inc., Lowers PT to $3.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ALIM

DateFirmActionFromTo
May 2016Cowen & CompanyDowngradesOutperformMarket Perform
Mar 2016Cantor FitzgeraldMaintainsBuy
Jan 2016Cantor FitzgeraldMaintainsBuy

View More Analyst Ratings for ALIM
View the Latest Analyst Ratings

Posted-In: News Reiteration Analyst Ratings

 

Related Articles (ALIM)